-
Company Insights
Johnson & Johnson – Digital Transformation Strategies
Johnson & Johnson Digital Transformation Strategies Report Overview Johnson & Johnson has been focusing on AI-based innovation as a part of its digital transformation strategies. The annual ICT spending of Johnson & Johnson was estimated at $793 million in 2023. A major share of this spending is earmarked for acquiring software, hardware, and consulting from vendors. Johnson & Johnson and its subsidiary companies are engaged in the research development, production, and sale of a variety of human healthcare and well-being...
-
Company Insights
Almirall – Digital Transformation Strategies
Almirall 2023 Digital Transformation Strategies Report Overview Almirall is leveraging several emerging technologies to quickly discover drugs, drive sales, streamline production, expand market presence, and help patients recover quickly. Cloud, AI, and digital therapeutics are among the technologies the company is focusing on. The annual ICT spending of Almirall is estimated at $14.7 million for 2023. A major share of this spending is earmarked for software, ICT services, and hardware. Almirall is a global biopharmaceutical company specializing in dermatology. The...
-
Company Insights
Pfizer Inc – Digital Transformation Strategies
Pfizer Inc Digital Transformation Strategies Overview Pfizer uses AI and data analytics to accelerate drug discovery and enhance operational efficiencies as a part of its digital transformation strategies. The annual ICT spending of Pfizer was estimated at $3.6 billion in 2022. A major share of this spending is earmarked for acquiring software, ICT services, and hardware from vendors. Pfizer Inc (Pfizer) discovers, develops, manufactures, and commercializes biopharmaceuticals. The company offers products to treat various conditions such as cardiovascular, metabolic and...
-
Product Insights
Dental Bone Graft Substitutes and Regenerative Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Dental bone grafts and substitutes are used to augment or fill a defect created by surgery, trauma, disease, or developmental deficiency. Bone grafts and regenerative materials regenerate the natural bone and dental tissue. The dental bone graft substitutes & regenerative materials pipeline market research report provides comprehensive information about the dental bone graft substitutes & regenerative materials pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in...
-
Case Studies
Use of Artificial Intelligence in Pharmaceutical Drug Development and Clinical Trials: Case Study
The pharmaceutical industry has a reputation as being risk averse to embracing new technologies and spent many years in “watch and wait” mode regarding artificial intelligence (AI). Compared to other industries, pharma has been slow to adopt AI, but there has been increased activity over the past few years. This case study provides an overview of how AI is currently being implemented by the pharmaceutical industry in drug discovery and clinical trials
-
Company Insights
Johnson and Johnson – Enterprise Tech Ecosystem Series
Johnson and Johnson has been strategically focusing on disruptive technologies such as AI & Machine Learning, Robotics, IoT, and Digital Therapeutics among various others to digitally transform legacy practices in business. The company has been focused on leveraging digital manufacturing techniques using 3D printing. J&J key accelerators, incubators, & other innovation programs include Janssen Business Development, JLABS, Janssen Disease Interception Accelerator (DIA), and JLINX among others. The company's investment portfolio comprises of Cala Health, BlackThorn, Zebra Medical Vision, Cara Care,...